Arctic Bioscience: New company presentation
Arctic Bioscience is pleased to announce that a new company presentation is now available.Arctic Bioscience, the company developing a novel oral treatment (HRO350) for mild-to-moderate psoriasis, a large global market with significant unmet medical need, is pleased to announce that a new company presentation is now available under the investor relations section on the company website and attached to this release.